Ann Neurol. 1977 Oct;2(4):299-303.

Inhibitors of GABA metabolism: implications for Huntington's disease.

Abstract

Stereotaxic injection of kainic acid into rat striatum produces neuronal degeneration and neurochemical alterations resembling Huntington's disease (HD). Since correction of the deficiency in gamma-aminobutyric acid (GABA) in HD may be of therapeutic value, the efficacy of drugs that inhibit the GABA-degrading enzyme (GABA-T) in elevating the levels of GABA has been examined in the animal model for HD. High doses of di-N-propylacetic acid only partially correct the GABA deficiency in the striatum, whereas low doses of gamma-acetylenic GABA, a specific irreversible inhibitor of GABA-T, completely restore the levels of GABA in striatum and substantia nigra.

PMID:: 152600; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Medical

Huntington's Disease - MedlinePlus Health Information

Molecular Biology Databases

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

An animal model for Huntington's disease. [Biol Psychiatry. 1979]
An animal model for Huntington's disease.
Coyle JT. Biol Psychiatry. 1979 Apr; 14(2):251-76.
Review Cellular compartments of GABA in brain and their relationship to anticonvulsant activity. [Mol Cell Biochem. 1981]
Review Cellular compartments of GABA in brain and their relationship to anticonvulsant activity.
Iadarola MJ, Gale K. Mol Cell Biochem. 1981 Sep 25; 39:305-29.
Intracerebral injection of gamma vinyl GABA: method for measuring rates of GABA synthesis in specific brain regions in vivo. [Life Sci. 1981]
Intracerebral injection of gamma vinyl GABA: method for measuring rates of GABA synthesis in specific brain regions in vivo.
Casu M, Gale K. Life Sci. 1981 Aug 17; 29(7):681-8.
On the use of enzyme inhibitors to study the synthesis and utilization of brain GABA. [Acta Pharmacol Toxicol (Copenh...]
On the use of enzyme inhibitors to study the synthesis and utilization of brain GABA.
Lindgren S, Andén NE. Acta Pharmacol Toxicol (Copenh). 1984 Jul; 55(1):41-9.
Review Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications. [Mol Cell Biochem. 1981]
Review Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
Gale K, Casu M. Mol Cell Biochem. 1981 Sep 25; 39:369-405.

See reviews... See all...

Cited by 2 PubMed Central articles

Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series. [BMC Neurol. 2006]
Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.
Saft C, Lauter T, Kraus PH, Przuntek H, Andrich JE. BMC Neurol. 2006 Feb 28; 6:11. Epub 2006 Feb 28.
Release-regulating autoreceptors of the GABAB-type in human cerebral cortex. [Br J Pharmacol. 1989]
Release-regulating autoreceptors of the GABAB-type in human cerebral cortex.
Bonanno G, Cavazzani P, Andrioli GC, Asaro D, Pellegrini G, Raiteri M. Br J Pharmacol. 1989 Feb; 96(2):341-6.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Inhibitors of GABA metabolism: implications for Huntington's disease.
Inhibitors of GABA metabolism: implications for Huntington's disease.
Ann Neurol. 1977 Oct ;2(4):299-303.

PubMed
Infrequent transmission of HIV-1 drug-resistant variants.
Infrequent transmission of HIV-1 drug-resistant variants.
Antivir Ther. 2004 Jun ;9(3):375-84.

PubMed
Loss of transfer RNA genes from the plastid 16S-23S ribosomal RNA gene spacer in...
Loss of transfer RNA genes from the plastid 16S-23S ribosomal RNA gene spacer in a parasitic plant.
Curr Genet. 1992 Apr ;21(4-5):417-22.

PubMed
In vivo cancer targeting and imaging with semiconductor quantum dots.
In vivo cancer targeting and imaging with semiconductor quantum dots.
Nat Biotechnol. 2004 Aug ;22(8):969-76. Epub 2004 Jul 18 .

PubMed
Signal molecules in systemic plant resistance to pathogens and pests.
Signal molecules in systemic plant resistance to pathogens and pests.
Cell. 1992 Sep 18 ;70(6):879-86.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Inhibitors of GABA metabolism: implications for Huntington's disease.

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Medical

Molecular Biology Databases

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information